| Literature DB >> 24926234 |
Nikolai Dembrow1, Daniel Johnston1.
Abstract
During goal-directed behavior, the prefrontal cortex (PFC) exerts top-down control over numerous cortical and subcortical regions. PFC dysfunction has been linked to many disorders that involve deficits in cognitive performance, attention, motivation, and/or impulse control. A common theme among these disorders is that neuromodulation of the PFC is disrupted. Anatomically, the PFC is reciprocally connected with virtually all neuromodulatory centers. Recent studies of PFC neurons, both in vivo and ex vivo, have found that subpopulations of prefrontal projection neurons can be segregated into distinct subcircuits based on their long-range projection targets. These subpopulations differ in their connectivity, intrinsic properties, and responses to neuromodulators. In this review we outline the evidence for subcircuit-specific neuromodulation in the PFC, and describe some of the functional consequences of selective neuromodulation on behavioral states during goal-directed behavior.Entities:
Keywords: neuromodulation; prefrontal cortex; projection neurons
Mesh:
Year: 2014 PMID: 24926234 PMCID: PMC4046580 DOI: 10.3389/fncir.2014.00054
Source DB: PubMed Journal: Front Neural Circuits ISSN: 1662-5110 Impact factor: 3.492
Figure 1(A) Schematic of descending connections from PFC to neuromodulatory centers showing the cellular targets of PFC fibers. Noradrenaline (NA) is released from terminals projecting from the locus coeruleus (LC). Cholinergic (ACh) terminals originate from the basal forebrain. Serotonin (5-HT) terminals originate from the medial and dorsal raphe nuclei (RN). Depending on the species of animal, terminals from the ventral tegmental area (VTA) and/or the substantia nigra (SN) are sources of dopamine (DA) within the PFC (for a review, see Berger et al., 1991). PFC fibers connect onto neuromodulator-synthesizing projection neurons (shaded circles), inhibitory interneurons (open diamonds), or both. In the case of locus coeruleus, PFC inputs synapse onto the dendrites of noradrenergic neurons. (B) Schematic of identified connections within the rodent mPFC. Pyramidal tract (PT, green) and intratelencephalic (IT, red) neurons are embedded within the PFC network differently. PT neurons are confined to L5/6 while IT neurons are found throughout L2-6. PT neurons receive inputs from PT, IT, and inhibitory interneurons. IT neurons receive only inputs from other IT neurons. L5 PT and IT neurons are shown in proximity for the purposes of the schematic, in the tissue they are interspersed amongst one another. Abbreviations: BF, basal forebrain; ACh, acetylcholine; VTA, ventral tegmental area; DA, dopamine; RN, raphe nuclei; 5-HT, serotonin; LC, locus coeruleus; NA, noradrenaline.
Figure 2Neuromodulators shift the dynamic properties of L5 PFC projection neurons. Pyramidal tract (PT, green) and intratelencephalic (IT, red) have different response profiles in their subthreshold (1–2) and spiking (3–5) properties. (1) Summation of synaptic inputs. In IT neurons, excitatory potentials spread out in time summate to trigger action potentials, while in PT neurons temporal summation is limited by intrinsic membrane properties. (2) While IT neurons respond preferentially to low frequency signals (1–2 Hz), PT neurons respond preferentially to theta frequency oscillatory input. (3) In response to a step current injection, PT neurons produce fewer action potentials than do IT neurons. (4) When synaptic activity is blocked, both neurons respond to depolarizing current steps, but return to quiescence once the stimulus is removed. In the presence of D2R activation or mAChR activation, PT neurons remain persistently active after the stimulus is removed. (5) A brief application of serotonin has opposing effects on active PT and IT neurons. Abbreviations: mAChR, muscarinic acetylcholine receptor; a2AR, alpha-2A-adrenergic receptor; D1R, dopamine subtype 1 receptor; D2R, dopamine subtype 2 receptor; mGluR, metabotropic glutamate receptor; 5-HT1A, serotonin subtype 1A receptor, 5-HT2A, serotonin subtype 2A receptor; NMDAR, NMDA receptor. Effects of neuromodulators are adapted from Dembrow et al. (2010); Avesar and Gulledge (2012); Gee et al. (2012) and Seong and Carter (2012).